Latest
-
A well known domestic PMS enters this midcap pharma name
OHM Investment Corporation acquired 314,939 shares of Panacea Biotec for approximately ₹15.52 crore, representing a 0.51% stake. This purchase is significant due to Panacea’s tightly held stock structure and indicates confidence in the company’s upward sentiment. The deal reflects institutional interest in an under-owned stock.
